APA

Schäfer S., Behling F., Skardelly M., Koch M., Ott I., Paulsen F., Tabatabai G. & Schittenhelm J. (20190123). Low FoxG1 and high Olig-2 labelling indices define a prognostically favourable subset in isocitrate dehydrogenase (IDH)-mutant gliomas. : Neuropathology and applied neurobiology.

Chicago

Schäfer S, Behling F, Skardelly M, Koch M, Ott I, Paulsen F, Tabatabai G and Schittenhelm J. 20190123. Low FoxG1 and high Olig-2 labelling indices define a prognostically favourable subset in isocitrate dehydrogenase (IDH)-mutant gliomas. : Neuropathology and applied neurobiology.

Harvard

Schäfer S., Behling F., Skardelly M., Koch M., Ott I., Paulsen F., Tabatabai G. and Schittenhelm J. (20190123). Low FoxG1 and high Olig-2 labelling indices define a prognostically favourable subset in isocitrate dehydrogenase (IDH)-mutant gliomas. : Neuropathology and applied neurobiology.

MLA

Schäfer S, Behling F, Skardelly M, Koch M, Ott I, Paulsen F, Tabatabai G and Schittenhelm J. Low FoxG1 and high Olig-2 labelling indices define a prognostically favourable subset in isocitrate dehydrogenase (IDH)-mutant gliomas. : Neuropathology and applied neurobiology. 20190123.